Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Early Clinical Use of Clascoterone▼
10
Mins
March 2026
Acne vulgaris (AV) is one of the most common inflammatory dermatological conditions affecting mainly adolescents, female adults, and…
Read more
9
Mins
26 Nov 2019
Considering Tomorrow in Today’s Treatment Choice of Women Living with Psoriasis
The objectives of this symposium were to understand the importance of planning treatment addressing the specific needs of women living…
9
Mins
26 Nov 2019
Epithelial Barrier Dysfunction in Type 2 Inflammatory Diseases
Type 2 immunity evolved from a dialogue between the immune system and microbes. This form of immunity confers protection against bacteria, viruses…
3
Mins
26 Nov 2019
Near Circumferential Invasive Proliferative Gelatinous Mass in the Calf: An Unusual Presentation of Hidradenitis Suppurativa
Hidradenitis suppurativa, or acne inversa, is a chronic, recurrent inflammatory disease of the skin and subcutaneous tissue characterised by painful…
6
Mins
26 Nov 2019
Serum Sickness-Like Reaction in Children: Review of the Literature
The main objective of this manuscript is to offer an organised and updated review of the clinical features and current treatment options for paediatric serum sickness-like reaction.
7
Mins
26 Nov 2019
Rosacea: The Patient Experience is Now 'CLEAR'
Prof Schaller posed the question “what makes rosacea so special?” and explained that the manifestations of rosacea are very varied, including papules…
11
Mins
26 Nov 2019
IL-23 Inhibitors for Moderate-to-Severe Plaque Psoriasis: A Review of Clinical Efficacy, Safety, and Tolerability
Psoriasis is a common, chronic, immune-mediated skin disease affecting approximately 2–3% of the global population…
5
Mins
28 Oct 2019
Pathways to Silencing Psoriasis: Remission or Cure?
Psoriasis occurs more frequently alongside other IMID, indicating common pathogenetic pathways. Many of these IMID show familial accumulation…
4
Mins
18 Oct 2019
Advances and Latest Insights in Non-Biologic Systemic Therapeutic Agents in Psoriasis and Atopic Dermatitis
The fumarates, monoethyl fumarate (MEF) and dimethyl fumarate (DMF), are potent ester derivatives of fumaric acid. Fumaric acid esters (FAE)…
10
Mins
17 Sep 2019
IL-23 Inhibition in Psoriasis: A Novel Approach to Convenient, Consistent Clearance
This sponsored symposium took place on 12th June 2019 in Milan, Italy, as part of the 24th World Congress of Dermatology (WCD), 2019
9
Mins
16 Sep 2019
Spotlight on Acne
This symposium took place on 13th June 2019, as part of the World Congress of Dermatology (WCD) symposium in Milan, Italy
4
Mins
12 Sep 2019
Scalp Sarcoidosis with Systemic Involvement: A Case Report and Literature Review
Sarcoidosis is a multisystem disease, of unknown aetiology, which can involve any organ of the body, even if it more frequently affects the lymph nodes…
9
Mins
11 Sep 2019
IL-23 Inhibition as a Key Component in Psoriasis Treatment is Here to Stay
Prof Elke de Jong focussed her presentation on data from randomised clinical trials (RCT) and real-world evidence (RWE) from psoriasis patient registries.
10
Mins
20 Aug 2019
Right Treatment to the Right Patient in Moderate-to-Severe Psoriasis: Discussion on Difference
Dermatologists frequently see psoriasis patients for whom the most troublesome symptoms are not the constant physical discomfort…
10
Mins
13 Jun 2019
Chemokine Pathway Can Be the Potential Therapeutic Target for Hypertrophic Scar
Hypertrophic scar (HTS) is a dermal form of fibroproliferative disease that develops after deep burns, skin injuries, and surgical wounds. HTS is defined…
10
Mins
13 Jun 2019
After Conventional Wisdom Has Failed, What Drives Wound Healing?
The purpose of this paper is to explore heat shock protein 90-alpha (Hsp90α)’s role as a potential driver of wound healing and as a possible future…
10
Mins
14 Mar 2019
Discover the Potential: Exploring New Frontiers of IL-23 Inhibitors
Affecting up to 11.4% of the population worldwide, psoriasis is one of the most common chronic autoinflammatory diseases.
9
Mins
14 Mar 2019
Clinical Conditions that Masquerade as Urticaria
Chronic urticaria is one of the most commonly diagnosed dermatoses. Following diagnosis, correct identification and proper treatment significantly reduces disease activity, thereby improving the patient’s quality of life.
10
Mins
12 Feb 2019
Translating Evidence to Practice: From Clinical Research to Real-World Experience
The goal of this programme is to support dermatologists to improve the management of patients with moderate-to-severe AD and bring together clinicians…
5
Mins
7 Feb 2019
Dimethyl Fumarate in Psoriasis Therapy
This presentation by Dr Weisenseel considered the role of fumaric acid esters (FAE) in plaque psoriasis.
9
Mins
29 Jan 2019
Unlocking the Potential of Immuno-Oncology in Advanced Cutaneous Squamous Cell Carcinoma: Role of Checkpoint Blockade
The rising incidence of CSCC presents a major challenge for healthcare systems and the frequency and impact of progression to advanced disease is…
8
Mins
13 Dec 2018
Translating Knowledge of IL-23 Targeting into New Solutions for Psoriasis Treatment
Following a brief introduction by Prof Lambert, the symposium started with an in-depth review of the current unmet needs in the clinical management of…
9
Mins
13 Dec 2018
Chronic Spontaneous Urticaria in Patients with Common Variable Immunodeficiency
Common variable immunodeficiency (CVID) is a predominantly antibody deficiency and is one of the most common primary…
10
Mins
30 Oct 2018
PASI 90/100, DLQI 0/1, and IL-17 Receptor/Cytokine: Does it Make a Difference and Are We Ambitious Enough?
The main objectives of the symposium were to review recent evidence on what difference targeting Psoriasis Area Severity Index (PASI) 90 or 100 and…
9
Mins
30 Oct 2018
Navigating the Road to Psoriasis Control in Women: Strategies to Optimise the Reproductive Journey
The importance of discussions around the management of women of childbearing age with psoriasis, an issue that has been largely neglected for many years…
10
Mins
30 Oct 2018
Is Complete Skin Clearance in Psoriasis the Answer?
Prof Reich outlined the new understanding of psoriasis pathogenesis, with IL-23 rather than IL-12 considered the pivotal cytokine pathway. This…
9
Mins
30 Oct 2018
IL-23 Inhibition in Psoriasis: Changing the Present, Shaping the Future
This symposium took place at the 27th European Academy of Dermatology and Venereology (EADV) Congress. The session examined the latest data for…
9
Mins
30 Oct 2018
From Evolution to Revolution: IL-23 in the Treatment of Psoriasis Patients
This symposium, which took place during the 2018 meeting of the European Academy of Dermatology and Venereology (EADV) in Paris, France, provided…
10
Mins
30 Oct 2018
Emerging Insights in the Treatment of Psoriasis and Psoriatic Arthritis
Guselkumab is a monoclonal antibody targeting IL-23 that is approved for the treatment of patients with moderate-to-severe plaque psoriasis. Two of…
9
Mins
30 Oct 2018
Efficacy, Sustainability, and Patient-Reported Outcomes of Guselkumab to Treat Plaque Psoriasis in the Post-Approval Setting
Plaque psoriasis is an autoimmune condition characterised by the development of red, dry, scaly skin lesions that cause irritation and pain for patients…
10
Mins
30 Oct 2018
Editor’s Pick: Beneath the Skin: The Relationship Between Psychological Distress and the Immune System in Patients with Psoriasis
Psoriasis is a chronic autoimmune skin disease with significant physical and psychiatric comorbidities and affects 2–3% of people worldwide.
5
Mins
30 Oct 2018
A Systematic Review on the Efficacy of Topical Acyclovir, Penciclovir, and Docosanol for the Treatment of Herpes Simplex Labialis
The objective of this study was to conduct a systematic review of the available evidence on the treatment of herpes simplex labialis with U.S. Food and Drug Administration (FDA)-approved topical antibiotics.
8
Mins
30 Oct 2018
Predicting Response to Omalizumab in Chronic Urticaria Based on Biomarkers
Chronic urticaria (CU) is characterised by intense recurrent itch, wheals, and/or angioedema, persisting for >6 weeks. CU can be subdivided into chronic…
10
Mins
30 Oct 2018
Lingual Pustular Psoriasis and Acrodermatitis Continua of Hallopeau Successfully Treated with Adalimumab: A Rare Case Report and Review of Oral Psoriasis
Psoriasis is a common skin disease with various cutaneous manifestations and is classified into two clinical groups: non-pustular and pustular.
8
Mins
9 Aug 2018
The Changing Landscape of Psoriasis: New Horizons for Oral Therapies
Prof Boehncke opened the symposium and highlighted the changing landscape of psoriasis management. On behalf of Prof Mrowietz, who was unable to attend…
6
Mins
9 Aug 2018
Psoriasis: From Gene to Clinic
Substantial developments over the last decade have advanced our knowledge and understanding of psoriasis, from both a basic scientific and clinical…
10
Mins
21 Jun 2018
A Review of the European Society for Photodynamic Therapy (Euro-PDT) Annual Congress 2018
This article reviews new data presented at the recent European Society for Photodynamic Therapy (Euro-PDT) Annual Congress 2018. The role of topical…
8
Mins
7 Jun 2018
Treating Psoriasis: What Is New About Fumaric Acid Esters?
This publication covers the first session of Almirall’s 11th Skin Academy meeting in Barcelona, Spain. This year, the meeting theme was ‘The Science of…
4
Mins
6 Jun 2018
Psoriasis and Direct-to-Consumer Advertising: A Useful Tool in Reducing Stigma?
The beginning of warmer weather brings optimism for most people as they emerge from winter. However, for those of us living with a highly stigmatised…
4
Mins
2 Mar 2018
The Impact of Social Media on Psoriasis Care
Social media platforms, such as Instagram, are particularly powerful when it comes to empowering psoriasis patients and reducing social stigma.
8
Mins
1 Mar 2018
Interleukin-23 in Psoriasis: Integrating New Therapies in the Current Treatment Landscape
Prof Reich welcomed delegates to the satellite symposium and explained that the aims of the meeting were to introduce the clinical role of targeted…
9
Mins
1 Mar 2018
From Registry Data to Real-Life Experiences: A Holistic Perspective of Psoriasis Treatment
Registries provide very high-quality data on the persistence of different therapies in the real world and can be used to compare and guide therapeutic…
7
Mins
1 Mar 2018
Interleukin-23 Inhibition as a Strategy to Treat Immune-Mediated Inflammatory Diseases
The satellite symposium comprised two short presentations aimed at providing an overview of the rationale for the use of interleukin (IL)-23 inhibition…
8
Mins
1 Mar 2018
Psoriasis: Beyond the Skin
Previously considered as just a skin condition, psoriasis has come to be regarded as a complex, systemic inflammatory disorder that affects multiple…
9
Mins
1 Mar 2018
Urticaria Diagnosis
Urticaria is a common skin condition that, though rarely fatal, can seriously impair a patient’s quality of life. Urticaria is caused by…
6
Mins
1 Mar 2018
When the Nail Appearance Plays Tricks: A Case of Longitudinal Melanonychia
This article presents a case of longitudinal melanonychia in a teenager with atypical signs and a good prognosis.
3
Mins
25 Jan 2018
Preventing Disabilities in Children Caused by Leprosy
This year, World Leprosy Day falls on Sunday 28th January. The occasion has been observed since 1954 and aims to raise awareness, providing more people…
10
Mins
30 Nov 2017
Tackling the Inflammatory Burden of Psoriasis: A Multidisciplinary Approach
Prof Girolomoni provided an overview of psoriasis, considering how patients are frequently affected by other comorbidities.
8
Mins
30 Nov 2017
Developments in the Treatment and Management of Psoriasis
The oral session consisted of a talk on the 2-year efficacy and safety of guselkumab in the treatment of moderate-to-severe psoriasis from the Phase III VOYAGE 1 trial.
7
Mins
30 Nov 2017
Linking Pathophysiology to Clinical Options in Psoriasis: New Insights into Interleukin-23
Prof Costanzo welcomed attendees to the symposium and outlined the agenda before explaining the autoimmune pathophysiology that underlies psoriasis.
9
Mins
30 Nov 2017
Proteomic Analysis of Antiprotease Immunoglobulin-E Anti-Sperm Autoantibodies in Chronic Urticaria After Vasectomy
Some types of chronic urticaria (CU) are associated with autoreactive immunoglobulin (Ig)E, as well as IgG. In the syndrome of autoimmune thyroid disease…
3
Mins
7 Nov 2017
My Experience with Isotretinoin
MY TREATMENT with isotretinoin was a long time coming. Having suffered for many years with severe acne, and with antibiotics only making a small dent in…
10
Mins
2 Nov 2017
Innovation That Drives Your Dermatological Future
This symposium is focused on topical therapies in the treatment of psoriasis and the unmet clinical and patient quality of life needs.
9
Mins
2 Nov 2017
Advancing Science: Driving Progress Today for a Clearer Tomorrow
Dermatologists today have more tools than ever at their disposal for managing psoriasis, including newer-generation biologics, which target molecular…
1
Mins
2 Nov 2017
Special Poster Feature: Certolizumab Pegol: A Future Treatment Option for Patients Suffering from Psoriasis
Psoriasis is a chronic inflammatory disease that is associated with a reduction in quality of life (QoL) and professional work productivity.
10
Mins
2 Nov 2017
Editor’s Pick: Hidradenitis Suppurativa (Acne Inversa): A Review of Aetiopathogenesis and Management
Hidradenitis suppurativa is a debilitating, chronic, relapsing inflammatory condition associated with the development of painful nodules.
9
Mins
2 Nov 2017
Chronic Urticaria in Children: A Review
In children, chronic urticaria is substantially less common than acute urticaria but is associated with a larger decrease in quality of life. Read to find out more.
9
Mins
2 Nov 2017
Psychosocial Issues in Dermatology
Skin, with its many biological functions, has a unique aesthetic value and determines the self-image and psyche of the person in terms of how they think…
8
Mins
2 Nov 2017
Hidradenitis Suppurativa: A Retrospective Review of 13 Patients and Literature Summary
Hidradenitis suppurativa is an inflammatory skin condition of the follicular pilosebaceous unit that primarily affects flexural areas where apocrine…
8
Mins
2 Nov 2017
Dermoscopy of Inflammatory Conditions: The Journey So Far
The use of dermoscopy in general dermatological practice has recently increased.
6
Mins
2 Nov 2017
Chronic Urticarial Vasculitis and Immunoglobulin-G Monoclonal Gammopathy: Variant Schnitzler Syndrome
Schnitzler syndrome is a rare acquired autoinflammatory disorder that is characterised by recurrent fevers, bone or joint pains, urticarial rash, and…
9
Mins
2 Nov 2017
Mind–Body Integrative Treatment of Psychodermatoses
The mind–skin interaction has been progressively clarified by recent research that has focussed on psychoneuroimmunology.
3
Mins
9 Aug 2017
Spasmodic Dysphonia: What About It?
Spasmodic dysphonia (SD): what about it? That is the million-dollar question.
5
Mins
2 Mar 2017
Haemangioma: A Review of the Literature and an Unusual Case Report
Haemangiomas are benign tumours growing by vascular endothelial hyperplasia, commonly occurring in females.
21
Mins
13 Feb 2017
Insuficiencia venosa crónica: manejo y tratamiento
La EVC es una enfermedad preocupante que genera una carga significativa sobre los servicios sanitarios y la sociedad en general.
15
Mins
13 Feb 2017
Chronic Venous Insufficiency: Management and Treatment
CVD is a very concerning condition which creates a significant burden on healthcare provision and wider society. Varicose veins are often the first sign of CVD.
9
Mins
15 Nov 2016
Useful Photoprotection in Dermatological Practice
The main objectives of this symposium were to explore the effect of light on individuals with hyperpigmentation disorders and acne, present the latest…
8
Mins
15 Nov 2016
Will Biosimilars Change the Treatment Paradigm in Psoriasis?
Prof Augustin opened the meeting and reviewed the use of systemic treatments recommended for moderate-to-severe psoriasis. Data indicating a lack of…
4
Mins
15 Nov 2016
Quality of Care: The Challenges, The Solutions
Psoriatic arthritis (PsA) and hidradenitis suppurativa (HS) are both immune-mediated diseases with common cellular and cytokine pathways involved in…
10
Mins
15 Nov 2016
Value in Psoriasis Care: From Patients to Payers
The symposium explored new approaches to optimising the value of psoriasis management from the perspective of physicians, patients, and healthcare…
9
Mins
15 Nov 2016
Editor’s Pick: The Role of Toll-Like Receptors and Antimicrobial Peptides in the Pathogenesis of Acne Vulgaris
Acne vulgaris (AV) is a chronic inflammatory disease of the pilosebaceous unit. AV has a multifactorial pathogenesis with specific roles played by the…
9
Mins
15 Nov 2016
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children: A Literature Review of Current Treatments
Stevens-Johnson syndrome and toxic epidermal necrolysis are among the most concerning drug reactions affecting adults and children. Although the overall…
7
Mins
15 Nov 2016
Significance of Diet and Oral Supplementation in Acne Vulgaris
Acne vulgaris is one of the most common skin diseases in the world. There are many factors involved in its pathogenesis. The dermatosis is characterised…
9
Mins
15 Nov 2016
Immunopathogenesis of Leprosy: A Model for T Cell Anergy
Leprosy is a model disease for understanding human immune responses underlying diseases caused by intracellular pathogens, as well as providing valuable…
10
Mins
15 Nov 2016
Reconstructive Options for Cutaneous Defects of the Nose: A Review
Background: The face is the most common site affected by skin cancer in the body and of the facial skin it is the nose that bears the brunt of the attack.
9
Mins
15 Nov 2016
The Main Neonatal Dermatological Findings: A Review
Background: The neonatal period is a phase of adaptation during which several skin conditions can develop. Most of these findings characterise the…
7
Mins
15 Nov 2016
Skin Manifestations Associated with Brucellosis
Brucellosis is a zoonotic infectious disease of worldwide distribution and is still endemic in some developing countries. Brucellosis is a systemic…
3
Mins
12 Jul 2016
A Call from a Patient to Openly Discuss Body Image in the Treatment of Type 1 Diabetes
Diabetes is a non-communicable disease (NCD) meaning that it often cannot be seen. After 20 years of living with Type 1 diabetes I am lucky to have no…
24 Nov 2015
Biologic Therapies: Clinical Practice in a Changing Environment
Biological therapies have been in use for treating psoriasis for a decade now, and they have greatly improved disease outcomes and quality of life…
24 Nov 2015
The Skin Microbiome in Patients with Acne Vulgaris
Changes in the composition of cutaneous microbial communities have been linked to several chronic inflammatory skin diseases, including acne.
24 Nov 2015
A Rejuvenation Therapy of Medical Needling and 3D-Matrixlift® is Safe and Improves the Elasticity of the Skin
The use of platelet-rich plasma and growth factors is emerging as an anti-ageing regimen for the skin.
24 Nov 2015
Acne and Systemic Diseases
Acne is a very common, multifactorial, complex, and chronic disease of the pilosebaceous unit that affects approximately 85% of adolescent patients and…
24 Nov 2015
Pyoderma Gangrenosum: A Mini-Review
Pyoderma gangrenosum (PG) is a rare, chronic neutrophilic dermatosis of unknown aetiology that usually presents with necrotising ulcers, although…
24 Nov 2015
Quality of Life Evaluation in Psoriasis Patients Starting a Biological Treatment: The Importance of a More Comprehensive Assessment of Disease Burden
Psoriasis is a chronic condition that has a significant negative impact on a patient’s quality of life (QoL).
24 Nov 2015
Staphylococcus Aureus and Atopic Dermatitis: Which Came First, the Chicken or the Egg?
Atopic dermatitis (AD) is a highly pruritic, chronic inflammatory skin disease that affects up to 25% of children and 10% of adults.
24 Nov 2015
Nasal Volumetric Remodelling with the Aid of a New, Stabilised Hyaluronic Acid Dermal Filler
Dermal fillers around the nose have become particularly popular among patients due to the minimally invasive aspect of these corrections.
24 Nov 2015
New Dermatological Indications for Pulsed Dye Lasers
Laser therapy has been classically focussed on three different chromophores: haemoglobin, melanin, and water, based on selective photothermolysis theory.
4
Mins
3 Mar 2015
When Does Bladder Cancer Get Its Turn?
The past decade, and particularly the past five years have been an exciting time in the management of prostate cancer. After what seemed like an eternity…
11 Dec 2014
Case Reports and Literature Review of Genital Psoriasis: Successful Therapy with Tacrolimus
Psoriasis is a chronic, inflammatory skin disease with a high prevalence in the general population. However, though psoriasis may involve all sites of…
5 Dec 2014
Contact Dermatitis, Cutaneous Barrier, and Sensitive Skin
Contact dermatitis (CD), one of the most common skin disorders, is one of the oldest but, at the same time, one of the newest diseases in dermatology.
24 Nov 2014
Optimising the Patient Journey in Chronic Spontaneous Urticaria
Summary of Presentations from the Novartis-Supported Satellite Symposium, held at the 23rd EADV Congress, Amsterdam, on 9th October 2014
24 Nov 2014
Revealing a Clear Path Towards a New Era in the Management of Psoriasis
The meeting provided a bench-to-bedside overview of the targeting of interleukin-17 (IL-17) for the treatment of psoriasis.
24 Nov 2014
The Recent Rapid Development of the Directed-Energy, Home-Use Device Sector
This article presents an overview of this exciting new technology category, the development of the industry, and future trends in at-home cutaneous…
24 Nov 2014
Current Concepts in Aesthetic Laser Medicine: The 694-Nm Q-Switched Ruby-Laser
Quality-switched (q-switched) laser systems are the gold standard for the treatment of benign pigmented lesions and tattoo removal. A frequently used…
24 Nov 2014
The Aetiopathogenesis of Psoriasis in 2014: An Update
Psoriasis is a common inflammatory skin disease and its immuno-aetiopathogenesis has been extensively studied, using both human clinical samples and…
24 Nov 2014
Primary Cutaneous Neutrophilic Disorders
The ‘classical neutrophilic dermatoses’ comprise a spectrum of disorders characterised by rash and neutrophilia. The defining histopathological finding…
24 Nov 2014
Neutrophilic Dermatoses Revisited
The neutrophilic dermatoses (ND) comprise a group of heterogeneous disorders characterised by inflammatory skin lesions that histologically show an…
24 Nov 2014
Skin pH in the Elderly and Appropriate Skin Care
The acidic skin surface pH (pHSS) plays a crucial role in the maintenance of a vital stratum corneum (SC) and an intact epidermal barrier.
24 Nov 2014
Isotretinoin and Psychiatric Effects
Isotretinoin is a vitamin A derivative that has been commonly used by dermatologists for the treatment of acne. Isotretinoin has many dose-related…
24 Nov 2014
Methylisothiazolinone and Methylchloroisothiazolinone: New Insights
Methylisothiazolinone (MI), along with Kathon™ CG (methylchloroisothiazolinone/MI), are widely used preservatives to prevent bacterial overgrowth in…
24 Nov 2014
Gram-Negative Bacterial Toe Web Intertrigo
Gram-negative infection of the toe web space is less frequent than dermatophytes and yeasts, but it is more challenging, especially with the involvement…
1
Mins
13 Feb 2014
Khellin in Vitiligo Treatment
Psoralens + UVA (PUVA) therapy is a well-known treatment for vitiligo, as well as Narrowband-UVB (NB-UVB), but other photochemotherapy regimens for vitiligo
11 Dec 2013
Resistance to Targeted Therapies in Melanoma: New Insights
Several molecular mechanisms are involved in melanoma genesis and progression. Molecular targets for effective therapeutic intervention have been…
11 Dec 2013
Skin Reactions Secondary to Anticancer Agents
In recent decades, new chemotherapeutic agents have been introduced in cancer therapy. The skin is often the target for their toxicity.
11 Dec 2013
Nail Changes in Recent and Old Leprosy Patients
Nails are elements of skin that can often be omitted from the dermatological assessment of leprosy. However, there are common nail conditions that…
Loading posts...
« Previous
1
…
28
29
30
31
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View